We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Mark - A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma
Tomer M Mark, MD, MSc
Weill Cornell Medical College
New York, New York, USA
12.06.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles